Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
Globe Newswire•14/08/2026•08:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.